Matt Abernethy, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,566 shares at $109.98 ($282K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Seasonal sale ($282k) by Chief Financial Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.98 | 1,283 | $141K | 50.0% |
| 2 | $109.98 | 1,283 | $141K | 50.0% |
| Total | $109.98 avg | 2,566 | $282K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $392K | — | Filing → |
| NBIX | SELL | 2024-08-15 | $2.1M | — | Filing → |